NDC 72189-582 – Buprenorphine Sublingual C-III

Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC72189-582

Product details

Brand name
Buprenorphine Sublingual C-III
Generic name
Buprenorphine Sublingual C-III
Labeler
Direct_Rx
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA078633
Marketed since
October 15, 2024
Listing expires
December 31, 2026
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine Sublingual C-III →

Package NDC codes (1)

Package NDCDescriptionSince
72189-582-6060 TABLET in 1 BOTTLE (72189-582-60)Oct 15, 2024

Other Buprenorphine Sublingual C-III products